Meeting Speaker for Tuesday, September 23, 2014
Professor Randi Hagerman is a Developmental and Behavioral Pediatrician and the Medical Director of the MIND Institute at UC Davis. She is internationally recognized as both a clinician and researcher in the fragile X field and she is the director of the Fragile X Research and Treatment Center at the MIND Institute and holds an Endowed Chair in Fragile X Research at UC Davis. Professor Hagerman received her M.D. from Stanford University where she also carried out her Pediatric residency. She completed a Fellowship in Learning Disabilities and Ambulatory Pediatrics at UC San Diego and, subsequently, spent the next 20 years from 1980 to 2000 at the University of Colorado where she headed Developmental and Behavioral Pediatrics. She co-founded the National Fragile X Foundation in 1984 in Colorado and developed a world-renowned fragile X research and treatment center. In 2000, Professor Hagerman moved to UC Davis to be the Medical Director of the MIND Institute. Dr. Randi Hagerman and Dr. Paul Hagerman and their team discovered the Fragile X-associated Tremor/Ataxia Syndrome (FXTAS) which is a neurological disorder that affects older carriers of fragile X.
Dr. Hagerman’s research involves genotype-phenotype correlations in fragile X and the association of fragile X and autism. Her greatest interest is in targeted treatments for fragile X syndrome, autism and premutation medical problems including FXTAS. Professor Randi Hagerman has written over 300 peer-reviewed articles and numerous book chapters on neurodevelopmental disorders. She has written several books on fragile X including a 3rd Edition of Fragile X Syndrome: Diagnosis, Treatment, and Research which was published in 2002 by Johns Hopkins University Press. She has also edited a new book Treatment of Neurodevelopmental Disorders: Targeting Neurobiological Mechanisms that just came out by Oxford University Press (2014).